subscribeSubscribe
Lupin receives FDA tentative marketing approval for generic Trijardy XR tablets

Lupin receives FDA tentative marketing approval for generic Trijardy XR tablets
PHARMABIZ
09 Jul 2024
Share Share
Lupin Pharm`s Generic Empagliflozin Receives Tentative Approval in US

Lupin Pharm`s Generic Empagliflozin Receives Tentative Approval in US
FDA
08 Jul 2024
Share Share
Lupin acquires two diabetes brands from Boehringer Ingelheim

Lupin acquires two diabetes brands from Boehringer Ingelheim
ECONOMIC TIMES
19 Aug 2023
Share Share
Sun`s Generic Empagliflozin, Linagliptin Receives Approval in the U.S.

Sun`s Generic Empagliflozin, Linagliptin Receives Approval in the U.S.
FDA
12 Jun 2023
Share Share
Sun`s Generic Linagliptin, Metformin HCL Receives Receives Approval in the U.S.

Sun`s Generic Linagliptin, Metformin HCL Receives Receives Approval in the U.S.
FDA
10 May 2023
Share Share
Zydus` Generic Linagliptin, Metformin Hydrochloride Receives Approval in the U.S.

Zydus` Generic Linagliptin, Metformin Hydrochloride Receives Approval in the U.S.
FDA
30 Mar 2023
Share Share
Zydus` Generic Linagliptin Receives Approval in the U.S.

Zydus` Generic Linagliptin Receives Approval in the U.S.
FDA
30 Mar 2023
Share Share
Torrent enters into co-marketing partnership with Boehringer Ingelheim India

Torrent enters into co-marketing partnership with Boehringer Ingelheim India
INDIANPHARMAPOST
15 Dec 2022
Share Share
PIII trial demonstrated Jardiance show reduction in blood sugar

PIII trial demonstrated Jardiance show reduction in blood sugar
BUSINESSWIRE
07 Dec 2022
Share Share
Pricing authority caps rates of key diabetes drugs

Pricing authority caps rates of key diabetes drugs
Teena Thacker ECONOMIC TIMES
25 Aug 2022
Share Share